Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide + vitamin C derivative + hyaluronic acid versus hydroquinone for facial melasma
RBR-4mkfmr8Recruiting
- Sponsor
- Universidade Estadual Paulista
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nicotinamide, hyaluronic acid and hydroquinone in melasma (2 arms), sponsored by Universidade Estadual Paulista. Started Feb 2023; status: recruiting.
02
Drugs
nicotinamidehyaluronic acidhydroquinone
03
Conditions
melasma
Beyond the preview
Go deeper on RBR-4mkfmr8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4mkfmr8.